These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7335376)

  • 1. Sensitivity of Bacteroides fragilis to seven antimicrobial agents.
    Oitmaa M; Benn R
    Pathology; 1981 Oct; 13(4):697-703. PubMed ID: 7335376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains.
    Wexler HM; Reeves D; Finegold SM
    Clin Ther; 1989; 11(6):828-33. PubMed ID: 2611824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation of anaerobic bacteria from clinical specimens and the drug susceptibility of Bacteroides fragilis].
    Ho SW; Hsien WC
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Jun; 10(1-2):8-13. PubMed ID: 578133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Fusobacteria in Antibacterial agents.
    Niederau W; Höffler U; Pulverer G
    Arzneimittelforschung; 1980; 30(12):2093-8. PubMed ID: 7194067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of carbapenem resistance in Bacteroides fragilis in China.
    Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
    Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of Bacteroides fragilis susceptibility patterns in France.
    Breuil J; Burnat C; Patey O; Dublanchet A
    J Antimicrob Chemother; 1989 Jul; 24(1):69-75. PubMed ID: 2777729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods.
    Klepser ME; Banevicius MA; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1941-4. PubMed ID: 8843310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in the susceptibility pattern of Bacteroides fragilis in four Detroit area hospitals.
    Bawdon RE; Rozmiej E; Palchaudhuri S; Krakowiak J
    Antimicrob Agents Chemother; 1979 Nov; 16(5):664-6. PubMed ID: 526009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteroides fragilis group: trends in resistance.
    Fille M; Mango M; Lechner M; Schaumann R
    Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization of antimicrobial disc susceptibility test for anaerobic bacteria.
    Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1976 Dec; 9(3-4):55-62. PubMed ID: 1037535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.
    Oteo J; Aracil B; Alós JI; Gómez-Garcés JL
    J Antimicrob Chemother; 2000 May; 45(5):691-3. PubMed ID: 10797095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.
    Katsandri A; Papaparaskevas J; Pantazatou A; Petrikkos GL; Thomopoulos G; Houhoula DP; Avlamis A
    J Clin Microbiol; 2006 Sep; 44(9):3465-7. PubMed ID: 16954304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new chromogenic medium for isolation of Bacteroides fragilis suitable for screening for strains with antimicrobial resistance.
    Tierney D; Copsey SD; Morris T; Perry JD
    Anaerobe; 2016 Jun; 39():168-72. PubMed ID: 27060277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
    Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
    Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.